Mizuho lowered the firm’s price target on Herbalife (HLF) to $7 from $9 and keeps a Neutral rating on the shares. The firm says 2025 opens with U.S. Food valuations near 20-year lows vs. the S&P 500 and weaker expectations for EPS given soft volumes and limited pricing power. In addition, continued uncertainty about demand related to GLP-1s and new regulatory concerns should limit investors’ appetites to own the space in the near term. Mizuho believes that most models remain capable of normalized positive mid- to high-single-digit EPS, but views 2025 as an investment year including rising potential for pricing adjustments across categories where consumption remains weak following inflation.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter